Using epigenetic networks for the analysis of movement associated with levodopa therapy for Parkinson's disease  by Turner, Alexander P. et al.
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Levodopa  is a  drug  that  is  commonly  used to treat  movement  disorders  associated  with  Parkinson’s
disease.  Its  dosage  requires  careful  monitoring,  since  the  required  amount  changes  over time,  and  excess
dosage  can  lead  to muscle  spasms  known  as  levodopa-induced  dyskinesia.  In  this  work,  we investigate
the  potential  for using  epiNet,  a  novel  artiﬁcial  gene  regulatory  network,  as a classiﬁer  for  monitoring
accelerometry  time  series  data  collected  from  patients  undergoing  levodopa  therapy.  We  also  considereywords:
pigenetics
rtiﬁcial gene regulatory networks
piNet
how  dynamical  analysis  of epiNet  classiﬁers  and  their transitions  between  different  states  can  highlight
clinically  useful  information  which  is not  available  through  more  conventional  data  mining techniques.
The  results  show  that epiNet  is capable  of discriminating  between  different  movement  patterns  which
are  indicative  of  either  insufﬁcient  or excessive  levodopa.
Publislassiﬁcation
arkinson’s disease
©  2016  The  Author(s).  
. Introduction
Since the beginnings of computer science, there have been
any successful attempts at capturing biological models within
 computational framework. This ﬁeld, known as bio-inspired
omputation, has given rise to algorithms which have been shown
o out-perform humans on real world tasks, for instance in object
ecognition (He et al., 2015). Indeed, many of the computational
lgorithms that are now state of the art are built upon bio-inspired
rinciples (Oquab et al., 2014; Hinton et al., 2012; Yang et al.,
013; Zhou et al., 2011). The design of bio-inspired algorithms
alls on a spectrum. At one end of this spectrum are attempts to
apture as much detail from the biological system as possible,
o best promote the possibility of emergent behaviour. At the
ther are intentionally minimalist approaches, using pared-back
odels that capture only an abstract representation of the bio-
ogical system. Each of these approaches has advantages, but
ften the simpler models are functionally complex and capable of
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capturing real-world biological dynamics (Bull, 2013; Wang et al.,
2012).
In this work we use a novel bio-inspired architecture, termed
epiNet, which is modelled upon the interactions between genetic
and epigenetic processes within biological cells (Turner et al.,
2015). Computational modelling of genetic processes, in the form of
artiﬁcial gene regulatory networks, is nothing new (Lones, 2016).
However, the inclusion of epigenetic elements allows for a con-
nectionist architecture with a dynamical topological morphology
– that is, the ability for a computational network to autonomously
partition itself and select partitions based upon environmental or
internal state. This serves two primary advantages. First, it sup-
ports task specialisation, where a partition assigned to a speciﬁc
environmental or internal context is only used in that scenario. Sec-
ondly, with minimal analysis it provides a method of characterising
a network’s behaviour from the ground up, by mapping the func-
tionality of the individual partitions and building up an image of the
system’s transitions between these partitions. This helps automate
the process of model validation. Because of this, we propose that
the properties of epiNet lend themselves well to the classiﬁcation
and analysis of real world time series data, where the underlying
generative model is often poorly understood.We describe the application of epiNet to the particular problem
of understanding and classifying the movements associated with
the neurodegenerative disorder Parkinson’s disease when a patient
is undergoing treatment with the dopamine replacement drug
s article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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copied from the genetic structure to the protein network. The pro-
tein network functions in a similar way to the networks in (Lones
et al., 2010), where it is the structure which directly interacts with
an external environment (task) and is executable. However, whichFig. 1. DNA being wound around histone oc
evodopa. Incorrect dosage of levodopa can have severe manifesta-
ions, notably the involuntary and violent muscle spasms known as
evodopa-induced dyskinesia (LID). Correct dosage involves ﬁnding
 balancing point between the removal of Parkinsonian symp-
oms and the onset of side-effects, providing a challenge to both
atients and clinicians alike. In this work, we demonstrate the
otential of epiNet by analysing the topological changes and transi-
ions between dynamical states within the model when classifying
ovement data collected during levodopa therapy. We  show that it
s possible to provide clinically relevant information about LID, the
nderlying data and the processes underpinning why at any given
oint epiNet has made a certain decision.
. Background
.1. Epigenetics
Epigenetics refers to mechanisms which result in changes in
ene expression without altering the underlying DNA (Bird, 2007;
urner, 2001). In Fig. 1, a general eukaryotic arrangement of DNA is
llustrated. Within the cell nucleus, DNA is wrapped around a his-
one octamer over 1.67 turns. This combination of DNA and histones
s referred to as chromatin, one of the major epigenetic structures.
hromatin has two prominent biological roles: compressing the
ize of a DNA strand, and controlling physical access to the DNA. The
ynamically varying structure of chromatin allows DNA to move
elative to it, allowing the cellular machinery (e.g. polymerase, tran-
cription factors) to access it. Controlling this movement means
ontrolling which genes are actively being transcribed at any given
oment. This idea is central to the model used within this paper,
here there exists a ‘bank’ of genes (the genome) which is inac-
ive by default. Then, chromatin reorganises itself relative to the
NA in order to change which genes are accessible to the cellular
achinery at any given time.
Additionally, there are other epigenetic marks. One of the most
ervasive is DNA methylation, where a methyl group is added to
ither the cytosine and adenine nucleotides within DNA. In a simi-
ar vein to chromatin modiﬁcations, methylations typically prevent
ranscription by physically inhibiting the cellular machinery’s abil-
ty to straddle the DNA, preventing processes such as transcription
Bird, 2007; Turner, 2001). There are also other epigenetic mecha-
isms, such as micro RNAs, prions and SRNAs.
.2. Epigenetic networks
The model used in this work (previously described in Turner
t al. (2015)), builds upon a range of previous work from more stat-
cally derived genetic and epigenetic functionality (representing
enetic networks and static epigenetic marks such as DNA methyl-
tion) (Lones et al., 2013; Turner et al., 2014; Reil, 1999; Bull, 2014)s over 1.67 turns, forming a chromatin ﬁber.
to more dynamic models which take inspiration from chromatin
modiﬁcations (Turner et al., 2013, 2015, 2016). Indeed, the low-
level element of epiNet, the artiﬁcial gene model, is derived from
(Lones et al., 2010), and remains unchanged. This artiﬁcial gene is a
computational element that takes inputs and processes them using
a function, producing a single transformed output. In this paper, we
use a sigmoid function, meaning that these low-level elements are
similar to perceptrons in artiﬁcial neural networks. This function
can be parameterised during evolution, allowing the gradient of the
function and offset to change for each individual gene, allowing for
functions ranging from the typical sigmoid to an approximate step
function (Fig. 2). Many of these genes are linked together to form
an artiﬁcial gene regulatory network, in which certain genes are
mapped to external inputs and outputs (Lones et al., 2010).
We have explored several approaches to building epigenetic
structures into, or on top of, existing artiﬁcial gene regulatory
networks (Turner et al., 2013, 2014, 2015). In these models, genes
are generally always active unless made inactive by an epigenetic
analogue. Additionally, the epigenetic analogues are static and ﬁxed
in place and control a small part of the network. With epiNet, by
comparison, genes are inactive until turned on by an epigenetic
analogue. The epigenetic analogues are then regulated by genes,
causing them to move around the genome, switching on and off
different parts of the network over the course of time.
The main structure in this model is a genetic structure, consist-
ing of a number of genes (30–100) which exist on a 1-dimensional
linear scale (Fig. 3) between [0,1]. These genes are static and are not
directly executed. Execution of the genes occurs when genes areFig. 2. The changes in the output of the sigmoid function according to different slope
parameters, which are optimised for each gene within the network. With a slope of
1,  the output can be seen to be a sigmoid with a shallow gradient. With a slope of
20,  the sigmoid gradient is steep enough to approximate a step function.
A.P. Turner et al. / BioSystem
Fig. 3. The components of epiNet. Genes that are covered by an epigenetic ana-
logue become expressed, forming a structure akin to a protein network. The protein
network then takes inputs from a task and is executed to produce output(s). The
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Evolutionary algorithms (EAs) are population-based meta-
heuristics which carry out optimisation procedures motivated by
biological evolution. Evolution is the process of adapting an indi-
vidual or population to environmental dynamics over successive
Table 1
Instances of each grade of dyskinesia.
Dyskinesia
UDysRS Count
0 4264pigenetic analogue is regulated by the protein network; following execution, it
eads expression levels in the protein network and passes them through a sigmoid
unction. The result then becomes the next position of the epigenetic analogue.
enes are copied from the genetic structure to the protein network
s controlled by the epigenetic molecule.
The epigenetic molecule(s) within epiNet straddles the genome,
xisting in the same 1-dimensional space. Each epigenetic molecule
as a position in this 1-dimensional space and a size (Fig. 1). The size
s ﬁxed, but the position is a variable. At each time step, whichever
enes exist within the space occupied by the epigenetic molecule
re then copied from the genome to the protein network. At each
ime step, the epigenetic molecule takes selected inputs from the
rotein network, and processes them using a sigmoid function
identical to the genes) and this output then becomes the epige-
etic molecules new position. Hence, the position of the epigenetic
olecule on the genome is the product of the structure and state
f the protein network. Upon initialisation, epiNet will contain 3
pigenetic molecules, however multiple epigenetic molecules can
e incorporated to the network throughout the optimisation pro-
ess. After each execution the protein networks expression values
re mapped back to the genome. This serves to give the protein net-
ork and genome a relative memory of its previous state. Following
xecution, all the proteins within the protein network are removed
nd will become repopulated according to the position of the epi-
enetic molecule on the next step. An external task can interface
ith epiNet by modifying protein expression within the protein
etwork. In this work, epiNets are initialised with 40 genes and 3
pigenetic molecules; however, new components may  be gener-
ted and removed allowing the modiﬁcation of their parameters
hroughout the course of evolution.
.3. Parkinson’s disease
Parkinson’s disease (PD) is a chronic neurodegenerative disor-
er which is characterised by progressively impaired motor control
ue to loss of dopaminergic neurons in the brain (Nalls et al.,
014). Although the underlying cause of Parkinson’s is unknown,
t has been linked to various genetic and environmental factors
Impellizzeri et al., 2015; Lolekha et al., 2010).
Currently approximately 1% of people over 60 suffer from PD;
owever, with a globally ageing population, it is estimated that
his will increase signiﬁcantly (Lill et al., 2012). Clinical diagnostic
ccuracy for PD is relatively low and research studies have shown
hat approximately 8–25% of cases are misdiagnosed (Schrag et al.,
002; Hughes et al., 1992). This is in part due to the overlap of
ymptoms associated with a range of other diseases including pro-
ressive supranuclear palsy, multiple system atrophy, corticobasal
yndrome, and vascular Parkinsonism. One of the most successful
reatments for the motor symptoms of Parkinson’s is a dopamine-
eplacement drug, levodopa. When using levodopa, there is ans 146 (2016) 35–42 37
issue of ﬁne tuning a patient’s medication to their exact require-
ments: insufﬁcient dosage results in ineffective treatment, excess
dosage can lead to levodopa-induced dyskinesia (LID), which may
manifest as violent muscle spasms. Clinicians ﬁne-tune a patient’s
medication regimens based on their own  ratings of the patient’s
symptoms and on patient-rated treatment response. These metrics
may  be insensitive to small but important effects and additionally,
these metrics correlate only weakly with each other (Fahn et al.,
2004). Moreover, it is often difﬁcult to separate the symptoms of
Parkinson’s from LID. Hence, a more personalised computational
approach is desirable, where dosage guidance can be inferred from
models trained using real patient data.
3. Methodology
The objectives of this work are:
• To understand the properties of epiNet as a predictive modelling
tool for the analysis of levodopa-induced dyskinesia
• To understand how the analysis of epiNet’s topological mor-
phology when classifying the data can provide useful clinically
relevant information about levodopa-induced dyskinesia
To achieve these objectives, we applied epiNet to the classiﬁca-
tion of real world medical data derived from accelerometers worn
by Parkinson’s patients undergoing a levodopa based medication
regime.
3.1. Clinical study data
The data was acquired from 25 patients who had conﬁrmed
symptomatic Parkinson’s disease and were being treated with lev-
odopa therapy. The patients wore small lightweight sensing devices
with integrated accelerometers and gyroscopes to monitor their
movements at a sample rate of 100 Hz. These devices each stored 6
channels of information, corresponding to acceleration in the three
translational and three rotational axes. The patients were uncon-
strained yet asked to complete various movement tests throughout
a 2 h window at non-speciﬁc intervals. Whilst doing this, the
patients were recorded using an infrared video camera. Trained
clinicians then used these recordings to grade the data, using the
Uniﬁed Dyskinesia Rating Scale (UDysRS) to mark up periods of LID.
The data was  cross-correlated between clinicians to ensure accu-
racy over the grading of the patients. The patients were rated on
a scale of 0–4, where 0 corresponds to the patient displaying no
signs of dyskinesia, and 4 corresponds to severe dyskinesia. Table 1
summarises the number of instances of each grade of dyskinesia
within the data set.
3.2. Evolutionary algorithms1 2004
2 2151
3 829
4 424
3 Systems 146 (2016) 35–42
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Fig. 4. Objective values for epiNet classiﬁers from the ﬁnal generations of 20 evo-
lutionary runs, showing performance on both the training and test sets. The x-axis
Fig. 5 summarises the distributions for both objectives. It is
notable that test set accuracies were signiﬁcantly higher for whole
data segments (more important from a clinical viewpoint) rather8 A.P. Turner et al. / Bio
enerations via the stochastic breeding of population members.
volutionary algorithms model this principle by using the data of a
ystem or model as a genome, and by crossing over and mutating
olutions within a population according to an objective measure
f their ability to solve a problem (known as their ﬁtness). Over
uccessive generations, the individuals’ ﬁtness will improve as the
opulation learns to solve a particular task.
EAs are relatively ﬂexible in how they represent and evaluate
olutions. Their appropriateness for optimising epiNets is also sug-
ested by the role of biological evolution in designing biological
enetic regulatory systems. For these reasons, we used them to
ptimise both the architecture and parameters of the epiNet model
n order to solve the problem of predicting the degree of dyskinesia
n segments of accelerometry time series data. We  used the multi-
bjective evolutionary algorithm NSGA-II (Deb et al., 2002) with a
opulation size of 400 and an optimisation period of 250 genera-
ions. We  used tournament selection of size 4. Point mutation was
sed for all components of the genome and epigenome with a prob-
bility of 0.05. The crossover operator exchanged 30% of the data
etween individuals, and the crossover rate is 0.5. These param-
ters were selected as previous exploratory experimentation has
hown that these allow for the evolution of complex behaviours
hich were not able to be learned by other algorithms within iden-
ical time frames (Turner, 2013; Turner et al., 2015).
We  use a multi-objective ﬁtness function in this work. The ﬁrst
bjective is to correctly classify each time step within a data seg-
ent, with one point awarded for each correct classiﬁcation. The
econd aggregates the points awarded for a data segment; if over
0% of the time points are correct, that data segment is considered
o be correctly classiﬁed and a point is awarded. This allows the
ystem to handle variable-sized data segments (204–16,001 time
teps) without biasing search towards classiﬁers that perform well
n only the shorter or longer samples, which tends to happen when
nly one of these objectives is used.
.3. Data handling
The complete data set contained 9672 labelled sequences. To
ake the optimisation process computationally tractable, we uni-
ormly sub-sampled (without replacement) 1000 instances for use
s a training set. The remaining samples were used for testing,
llowing a fairly robust estimate of a classiﬁer’s generality.
The data was split into 2 classes of dyskinesia severity: high and
ow. High indicates an LID rating of either 2, 3 or 4. These correspond
o clinically signiﬁcant levels of dyskinesia that require a change in
evadopa dosage. Low indicates an LID rating of 0 or 1, i.e. no, or
ery mild, dyskinesia. The training data was split accordingly; the
ow class comprising 500 data segments, with 250 rated 0 and 250
ated 1, the high class comprising 500 data segments with 166 rated
, 167 rated 3, and 167 rated 4.
Each data segment comprises 6 times series, corresponding to
hanges of acceleration over time in the three translational and
otational axes. At each time step, this multivariate data is fed into
n epiNet classiﬁer as a group of 6 values, each copied into the
ctivation levels of input genes. After the epiNet has processed the
nput, a single output is read from the expression level of an out-
ut gene. An output value below 0.5 is interpreted as indicating
ow dyskinesia; a value equal to or greater than 0.5 indicates high
yskinesia.
. ResultsWe  carried out 20 independent runs, during which each epiNet
lassiﬁer was evaluated on its ability to correctly predict the labels
f each time step and each data segment within the training set.shows the proportion of time steps which were correctly classiﬁed and the y-axis
shows the proportion of data segments which were correctly classiﬁed (i.e. where
at  least 50% of the time steps within each segment were classiﬁed correctly).
Following these 20 runs, all the ﬁnal generation classiﬁers were
re-evaluated on the test set. Fig. 4 shows the performance of these
controllers on both the training and test sets, with each point show-
ing the per-step and per-segment accuracy of a single controller.
On the training set, classiﬁers were found with accuracies of ∼80%.
When re-evaluated on the test set, accuracies dropped to around
∼70%; however, most showed an ability to generalise.Fig. 5. Distributions of objectives values amongst the ﬁnal generation epiNet clas-
siﬁers, showing per-step and per-segment classiﬁcation accuracies for both the
training and test sets. This is a transformation of the data shown in Fig. 4.
Systems 146 (2016) 35–42 39
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Fig. 6. An epiNet’s dynamics at each time step when classifying a single data seg-
ment, showing the activity of each gene, the positions of the epigenetic molecules
and the output from the network. This network classiﬁed 53% of the time stepsA.P. Turner et al. / Bio
han individual time steps. This is unsurprising, given the larger
mount of historical time series data present in an entire data seg-
ent, and the relative stochasticity of movements at a single time
tep. However, it is also evident from Fig. 4 that the majority of the
lassiﬁers are fairly balanced in their responses at the per-step and
er-segment level, with most clustered along the diagonal.
.1. Analysis of network dynamics
The results show that trained instances of the epiNet model
re capable of classifying movements associated with levodopa
herapy. We  next carried out post-hoc analysis of the dynamical
ehaviour of the epiNet classiﬁers, in order to gain some insight
nto how they achieve this.
Figs. 6 and 7 show the dynamical response of a single evolved
piNet classiﬁer whilst processing two different acceleration time
eries data segments. First of all, it is evident that the dynamics of
he network are adaptive, with the activation levels of the genes
nd the positions of the epigenetic analogues undergoing signif-
cant changes during the course of classiﬁcation. This change in
ynamics is caused by the autonomous topological changes of the
etwork as a result of changing dynamics in the environmental
nput data. Analysis of a sample of the evolved classiﬁers sug-
ests that this behaviour is typical, with <5% of the instances not
ndergoing topological change whilst processing the input data,
nd these topologically-invariant solutions having generally lower
tness values. This suggests that topological change is a useful
echanism, and it seems likely that topological changes are driven
y, and hence are a signal of, dynamical changes in the patient’s
ovements.
For the network analysed in Figs. 6 and 7, some genes are almost
lways active (approximately 3–5), some genes are never active,
nd others are intermittently active. Additionally, the size of the
xpressed network varies signiﬁcantly over time; sometimes no
enes are active, sometimes upwards of 15 are active. It can also
e noticed (particularly in Fig. 7) that some changes in the activity
f the genes do not lead to changes in the overall dynamics of the
etwork. For example, at time steps 220–800, gene 31 is constantly
eing activated and deactivated, yet this causes no discernible dif-
erence in the network’s output.
The evolutionary algorithm was given the freedom to evolve
he architecture of the epiNets within bounds. The initial param-
ters for the network were 40 genes and 3 epigenetic molecules
nd most networks maintained a similar architecture throughout
ptimisation. The number of genes varied little, with the largest
olutions containing 52 genes, the smallest containing 30. There
ppeared to be no discernible difference between the performance
f networks based on the number of genes alone. Most functional
olutions contained 3 epigenetic molecules. However, a signiﬁcant
umber contained only 2, but these otherwise functioned similarly
o the networks containing 3: suggesting that useful behaviour can
e achieved with less molecules, but with some impairment to evol-
ability. Networks which contained 1 or 4 epigenetic molecules had
oor functionality, with neither of them resulting is a solution in
he top 20% of the population. A possibility, as seen is previous work
s that too many epigenetic molecules leads to a greater likelihood
f interference between regulatory regions.
.2. Knowledge extraction
The data used to train the networks contains 6 input channels
nd a single output. EpiNet allows these inputs to be mapped onto
enes multiple times (i.e. one input gets mapped onto multiple
enes); it also allows particular inputs to be ignored by the net-
ork (Fig. 8). To understand the way in which epiNet classiﬁers
se the inputs, we analysed the best evolved solutions.correctly, leading to a correct classiﬁcation for the segment. The network shows
somewhat disordered dynamics and appears not to remain in a dynamical regime
for more than around 200 time steps. This is the same network as in Fig. 7.
A pervasive trend was for 3 of the 6 inputs to be used signif-
icantly more than the others, although none of the high ﬁtness
networks used a permanently static mapping. Inputs 2, 3 and 6
were a common choice; however, 4 and 5 were also used widely
in other networks. It was also common for input 1 (acceleration in
the x-plane) to be completely ignored by the networks. In many
solutions, single inputs were mapped onto multiple genes (mostly
2, sometimes 3 or 4), which were then excited in tandem. Hence,
a particular input could drive multiple regulatory circuits. This can
be interpreted as an indication of the relative importance of the
input variable. However, over the course of execution, not all inputs
remained in use. This can be seen as a context sensitive switch, with
input signals driving topological change that causes the network to
40 A.P. Turner et al. / BioSystems 146 (2016) 35–42
Fig. 7. An epiNet’s dynamics at each time step when classifying a single data seg-
ment, showing the activity of each gene, the positions of the epigenetic molecules
and  the output from the network. This network classiﬁed 91% of the time steps cor-
rectly, leading to a correct classiﬁcation for the segment. After the ﬁrst 200 steps a
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Fig. 8. A typical evolved mapping of the accelerometer inputs to genes. Certain
This suggests that it is possible to train effective classiﬁers using
only a single channel of the accelerometry data. This is signiﬁcant,
as it could considerably reduce the training time of the networks. Ittable regime is maintained with only minor changes in the dynamics thereafter.
his is the same network as in Fig. 6.
ocus on movement in particular axes. For instance, for over 75% of
he networks’ execution, half of the inputs are not used.
For further analysis, we looked at creating a minimum work-
ng example (MWE)  of an evolved solution, assuming that evolved
piNets would be architecturally more complex than they needed
o be in order to solve the problem. This was  done by itera-
ively removing a gene from the network and then re-evaluating
t. If the performance worsened, the gene was replaced; if not, it
as removed permanently. The epiNet architecture is particularly
obust to deleterious mutations as its genes are not all intercon-
ected during execution, and it is therefore unlikely that all of the
ynamical regimes of the network would be affected by a singleinputs are mapped onto different genes which are close in proximity. These genes
are often executed together. In addition, each solution tends to ignore one of the six
inputs permanently.
gene deletion. We  found that removing genes had a less damag-
ing effect to the networks’ performance then removing epigenetic
molecules, which almost always adversely affected performance.
The networks we  considered initially started with 40 genes, and in
general could be reduced to around 5 genes (Fig. 9). Although this
had no effect on functionality, the networks in this state were more
sensitive to perturbations; because of this increased sensitivity, it
is probable that they lacked the ability to move through the search
space in as timely a manner as the original networks, as small per-
turbations would be likely to dramatically alter behaviour. Because
these networks were artiﬁcially created by removing genes, it is
difﬁcult to fully assert what the networks structure would be if
they were evolved to be as small as possible. However, in previous
work (Turner et al., 2015) it was shown that doing such, removed
the robustness of the networks during execution, but the networks
were still able to ﬁnd solutions to complex tasks. Hence it is likely
that artiﬁcially altering network structure has different effects than
evolving the networks to do so.
The functioning of an MWE  version of the network analysed in
Fig. 9 is depicted in Fig. 10, showing the activity of each gene over
a transitional period. This network was capable of classifying both
time steps and data segments with over 69% accuracy. It can be seen
that genes 1 and 5 initially oscillate. Whilst in this dynamical phase,
the network is completely inactive for 50% of the time. Once the
transition occurs, genes 3 and 4 become permanently active. This
switching behaviour was common in the MWEs, and in general the
networks appeared to have two  stable attractors corresponding to
movements in the high and low dyskinetic classes. The transition
between attractors was  also, in most cases, permanent, suggesting
that once a signiﬁcant dyskinetic signal was  detected, the network
remained in the high dyskinesia state, increasing the likelihood of
classifying the whole segment as exhibiting dyskinesia. For most
MWEs, it was  also evident that the transition between attractors
was governed by a single input. Although other inputs might be
mapped to genes after this transition, the permanent change in
attractor meant that they were not being used.Fig. 9. Mapping of the accelerometer inputs to genes in the smallest network created
by  iteratively removing genes and re-evaluating. This network contained only 5
genes and 2 epigenetic molecules.
A.P. Turner et al. / BioSystem
Fig. 10. The activity of each gene in the minimum working example depicted in
Fig. 9. Initially genes 1 and 5 are oscillating, where at one time step they are both
active, and at the next, neither are active. At these points the entire network is com-
pletely inactive. At time step ∼1475, the network changes and starts continuously
executing genes 3 and 4 after a single execution of genes 2, 3 and 4. The transition
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A.M., 2013. Artiﬁcial biochemical networks: evolving dynamical systems toetween gene activity shown is the only transition during the 3500 steps in this data
nstance.
lso means that patients could be ﬁtted with simpler sensors that
onsume less energy and are therefore less bulky. Furthermore, the
WE  equivalents of the evolved classiﬁers are quite small. In prin-
iple, this means they could be implemented in a relatively small
igital (or potentially analogue) circuit deployed within a sensor
latform. This could provide a single-device solution to monitoring
yskinesia in Parkinson’s patients.
.3. Conclusion
In this paper we have shown that epiNet is able to clas-
ify levodopa-induced dyskinesia within patients suffering from
arkinson’s disease. We  have also shown how analysis of an
piNet’s structure can give us insight into both how and why clas-
iﬁcation decisions have been made. In particular we showed that
ost-processing of the networks could often reduce the number of
enes in the network from 40 to around 5 without altering func-
ionality. This also showed that the networks could make decisions
ased on a single accelerometer input, signiﬁcantly increasing the
fﬁciency of execution. This opens up the opportunity for small,
earable diagnostic tools to be implemented using a hardware
odel of the MWEs.
The results are promising, however, there were speciﬁc caveats
ssociated with the work in this paper. The ﬁrst is that the com-
ination of population based evolutionary algorithms and epiNet
eant that run times were relatively high. This limited the scope
f the networks ability to learn, but conversely, also allowed for a
omprehensive method of testing because a large amount of data
as not used in training. It would have also been beneﬁcial to
llow for a larger population size and more generations to gather
 better understanding of epiNet’s potential. A further possibility
o improve this is to migrate the software to a GPU implementa-
ion as a signiﬁcant part of the processing within the networks is
oating point arithmetic, hence, the performance increase should
e substantial. Within this work there has not been a direct focus
n objective performance, but a focus on the underlying dynam-
cs of the networks when classifying high frequency movement
ata. Because of the novel dynamical properties of the network,
e feel that direct comparison with other techniques with differ-
ng dynamical functionality would at present be of limited value
s variations in performance could be attributed to the parameters
f the respective techniques. The work in this paper is to be used
s an underpinning of future research in which a robust analysiss 146 (2016) 35–42 41
of epiNets performance will be carried out in reference to other
models, such as those in Lones et al. (2014b).
Within this work we  had to reclassify the data into either a high
or low levodopa-induced dyskinesia rating. In addition, there was  a
class imbalance where there was an order of magnitude more data
available data sets with no levodopa-induced dyskinesia, compared
to those who  had the most pronounced symptoms. Hence, it might
be possible to look at a class weighting which is dependent on clas-
siﬁcation outcomes (and how incorrect classiﬁcations may  effect
patients) and the relative performance of the networks. Indeed, it
may  also be beneﬁcial to look at re-balancing the classes by omit-
ting certain classiﬁcations within the data (to only focus on the
most severe symptoms) as seen in Lones et al. (2014a).
Overall, the results in this paper have shown that epiNet has
signiﬁcant potential as a classiﬁcation tool, and that the analysis
of the network structure and dynamics can provide clinically rel-
evant information about the decisions made by epiNet which are
important both for patient outcome and model validation.
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